- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Deadline Alert: Boston Scientific Shareholders Urged to Contact Law Firm About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP reminds investors of upcoming deadline to file lead plaintiff motion in class action lawsuit against Boston Scientific Corporation.
Mar. 16, 2026 at 6:55pm
Got story updates? Submit your updates here. ›
Glancy Prongay Wolke & Rotter LLP is reminding investors of the upcoming May 4, 2026 deadline to file a lead plaintiff motion in a class action lawsuit against Boston Scientific Corporation. The lawsuit alleges that Boston Scientific made materially false and misleading statements about its U.S. Electrophysiology segment, including overstating its growth potential and failing to disclose increased competition that was limiting the company's growth.
Why it matters
This lawsuit is significant for Boston Scientific shareholders who may have lost money due to the company's alleged misrepresentations about its business. The outcome could result in financial recovery for affected investors.
The details
The lawsuit alleges that Boston Scientific failed to disclose that the growth rate of its U.S. Electrophysiology segment was unsustainable and facing earlier-than-expected competition, which was limiting the company's growth potential. Despite these issues, the company allegedly made repeated statements expressing confidence in the division's growth trajectory and provided elevated full-year guidance metrics that were misleading.
- The class period covers July 23, 2025 to February 3, 2026.
- The deadline to file a lead plaintiff motion is May 4, 2026.
The players
Glancy Prongay Wolke & Rotter LLP
A law firm representing investors in the class action lawsuit against Boston Scientific Corporation.
Boston Scientific Corporation
A medical device company that is the defendant in the securities fraud lawsuit.
What’s next
The judge will decide on May 4, 2026 whether to appoint a lead plaintiff in the class action lawsuit.
The takeaway
This lawsuit highlights the importance of transparency and accurate disclosures by public companies. Investors who suffered losses due to Boston Scientific's alleged misrepresentations may be able to recover those losses through this class action.
